BiotechTube

Diosmectite (Smecta®)

ApprovedCompleted
0 watching 0 views this week🔥 Hot
82
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Diarrhea

Conditions

Diarrhea

Trial Timeline

Jan 1, 2005 → Jul 1, 2006

NCT ID
NCT00276328

About Diosmectite (Smecta®)

Diosmectite (Smecta®) is a approved stage product being developed by Ipsen for Diarrhea. The current trial status is completed. This product is registered under clinical trial identifier NCT00276328. Target conditions include Diarrhea.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (2)

NCT IDPhaseStatus
NCT03045926Phase 1Completed
NCT00276328ApprovedCompleted

Competing Products

20 competing products in Diarrhea

See all competitors
ProductCompanyStageHype Score
YM060 + PlaceboAstellas PharmaPhase 3
77
Fidaxomicin oral suspension + Fidaxomicin tablets + Vancomycin oral liquid + Vancomycin capsulesAstellas PharmaPhase 3
77
YM060Astellas PharmaPhase 3
77
RamosetronAstellas PharmaPre-clinical
23
Racecadotril Film-Coated Tablet (FCT) + Racecadotril CapsuleJohnson & JohnsonPhase 1
33
loperamide-simethicone + matching placeboJohnson & JohnsonApproved
85
Racecadotril + Racecadotril + Racecadotril + RacecadotrilJohnson & JohnsonPhase 1
33
Loperamide/simeticone 2 mg/125 mg caplets + Loperamide/simeticone 2 mg/125 mg chewable tablets + Probiotic Saccharomyces boulardii 250 mg capsulesJohnson & JohnsonApproved
85
fidaxomicin + PlaceboMerckPhase 3
77
Surotomycin + PlaceboMerckPhase 1
33
Surotomycin + PlaceboMerckPhase 1
33
OPT-80MerckPhase 2
52
fidaxomicinMerckPhase 2
52
RV5 (Pentavalent Rotavirus Vaccine)MerckApproved
85
LJN452 + Placebo to LJN452NovartisPhase 2
52
Octreotide Long Acting ReleaseNovartisPhase 3
77
DNK333 + PlaceboNovartisPhase 2
52
Probiotic SupplementRochePre-clinical
23
Etrasimod + Placebo + CorticosteroidsPfizerPhase 2
51
Calcium Carbonate + nelfinavir + lamivudine + loperamide + nelfinavir + lamivudine + zidovudinePfizerPhase 3
76

Other Products from Ipsen

AbobotulinumtoxinA + PlaceboApproved
82
lanreotide acetateApproved
82
Tigan® + PlaceboApproved
82
lanreotide (Autogel formulation)Approved
82
Decapeptyl® SR 22.5mg + Decapeptyl® SR 11.25mg; Prostap® 3 DCS 11.25mg; Zoladex® LA 10.8mgApproved
82